World Health Organization Raises Concern Over Critical Lack of Obesity Injections
Less than 10% of patients who could benefit from weight-loss injections including Wegovy have access to them, states the World Health Organization as it publishes its first advice on the drugs.
Given in excess of 1,000,000,000 individuals worldwide currently living with obesity, it is calling for broader and more equitable availability to GLP-1 medication.
According to estimates, over two billion could be living with obesity by 2030 without intervention.
"Our latest guidance recognises that excess weight is a lifelong illness that can be managed with thorough and ongoing support," stated its chief Tedros Adhanom Ghebreyesus.
Significant expense, insufficient output, and supply-chain constraints are major barriers to widespread availability to the treatments that can assist patients in reducing considerable body mass, explains the body.
Weight-Loss Drug Shortage
Even under the current best projected outlook, the manufacturing of such drugs might only reach approximately 100 million people – less than 10% of those who need them, according to the health organization.
The recommendation calls on nations and manufacturers to expand availability, by approaches like licensing agreements.
The intellectual property rights on semaglutide – the primary component of the drug Wegovy – is due to expire in a number of countries in 2026.
How Obesity Jabs Work
GLP-1 drugs replicate a natural hormone to delay gastric emptying, reduce hunger and increase feelings of fullness so people consume fewer calories.
People typically start to lose weight after several weeks of commencing the regular doses.
Evidence indicates people may regain a significant portion after a year of halting the treatment, when their typical hunger resume.
To be carrying excess weight elevates your likelihood for experiencing medical conditions, like diabetes, heart disease, brain attack, and certain malignancies.
Obesity affects people in countries worldwide and was linked to 3.7 million fatalities worldwide in 2024, according to the health agency.
